Showing 1581-1590 of 2235 results for "".
- New ASPS Data: Minimally Invasive Aesthetic Procedures Up 200 Percent Since 2000https://modernaesthetics.com/news/new-asps-data-minimally-invasive-aesthetic-procedures-up-200-percent-since-2000/2472125/Drumroll, please… Plastic surgery is on the rise, according to the annual statistics from the American Society of Plastic
- Galderma's Restylane Silk Approved for Injection via Cannula for Lip Augmentationhttps://modernaesthetics.com/news/galdmeras-restylane-silk-approved-for-injection-via-cannula-for-lip-augmentation/2472175/The FDA approved the use of a small blunt tip cannula with Restylane Silk for lip augmentation. Galderma's Restylane Silk was the first FDA-approved hyaluronic acid (HA) dermal filler specifically designed for lip augmentation and the smoothing of wrinkles around the mouth in patients 21 year
- Deadline Extended for Medical Spa State of the Industry Statistical Studyhttps://modernaesthetics.com/news/deadline-extended-for-medical-spa-state-of-the-industry-statistical-study/2472272/The American Med Spa Association (AmSpa) has extended the deadline for the 2017 Medical Spa St
- Case Report Describes Dual-Phase CL Code for Facial Rejuvenationhttps://modernaesthetics.com/news/case-report-describes-dual-phase-cl-code-for-facial-rejuvenation/2486484/A case report in the April 2026 issue of Journal of Cosmetic Dermatology described a dual-phase injectable approach to facial rejuvenation that combined contour restoration with ligamentous support using a polycaprolactone-based collagen stimulator. The authors termed the method the “CL
- GPX4 Modulator Shows Early Promise in First-in-Human Studyhttps://modernaesthetics.com/news/gpx4-modulator-shows-early-promise-in-first-in-human-study/2486474/A novel topical therapy targeting cellular senescence showed early biologic activity across multiple dermatologic conditions in a Phase 1 clinical trial, according to data presented by Frederick Beddingfield III, MD, PhD, FAAD, at the Dermatology Innovation Forum during the American Academy of De
- SkinPen Milestone Highlights Growth in Microneedling Demandhttps://modernaesthetics.com/news/skinpen-milestone-highlights-growth-in-microneedling-demand/2486459/Revance announced that it has distributed more than 1 million SkinPen treatment kits nationwide since January 2025, marking a milestone for the company’s microneedling portfolio. The achievement comes approximately 1 year after the launch of SkinPen Precision Elite, the latest iteration of the de
- Study Supports Safety, Efficacy of Subcutaneous Forehead Lift for Upper Facial Aginghttps://modernaesthetics.com/news/study-supports-safety-efficacy-of-subcutaneous-forehead-lift-for-upper-facial-aging/2486458/A retrospective analysis published in Frontiers in Surgery evaluated the effectiveness and safety of subcutaneous forehead lift (SFL) for reducing horizontal forehead and glabellar wrinkles using the validated Wrinkle Assessment Scale (WAS). The study included 697 patients treated at a s
- AAD 2026: Allergan Aesthetics Highlights TrenibotE Data and GLP-1 RA Patient Trendshttps://modernaesthetics.com/news/aad-2026-allergan-aesthetics-highlights-trenibote-data-and-glp-1-patient-trends/2486432/Allergan Aesthetics, an AbbVie company, presented four posters at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, including new findings on repeat treatment with investigational trenibotulinumtoxinE (TrenibotE) and insights into aesthetic trends among patients r
- AAD 2026: RelabotulinumtoxinA Shows Consistent Efficacy Across Age Groupshttps://modernaesthetics.com/news/aad-2026-relabotulinumtoxina-shows-consistent-efficacy-across-age-groups/2486431/A post hoc analysis presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, evaluated the impact of age on outcomes with relabotulinumtoxinA in patients with moderate-to-severe glabellar lines (GLs) and lateral canthal lines (LCLs). The analysis pooled data
- AAD 2026: Lumenis Launches triLIFT 2.0 for Combined Muscle and Skin Rejuvenationhttps://modernaesthetics.com/news/lumenis-launches-trilift-20-for-combined-muscle-and-skin-rejuvenation/2486430/Lumenis Be Ltd. announced the commercial launch of triLIFT 2.0, a next-generation platform designed to deliver combined muscle stimulation and skin rejuvenation for facial and body applications. The system integrates Dynamic Muscle Stimulation technology (DMSt) with FibroBoost, aiming to address